Complications of Acute Coronary Syndromes
KEYWORDS: ventricular, patients, atrial, infarction, left, usually, left ventricular, heart, block, myocardial, fibrillation, myocardial infarction, failure, tachycardia, treatment

medications (eg, lidocaine) increases mortality risk and is not recommended. After the acute phase, the presence of complex ventricular arrhythmias or nonsustained ventricular tachycardia, especially with significant left ventricular systolic dysfunction, increases mortality risk. An implantable cardioverter-defibrillator (ICD) should be considered and is indicated when the left ventricular ejection fraction is < 35%. Programmed endocardial stimulation can help select the most effective antiarrhythmics or determine the need for an ICD. Before treatment with an antiarrhythmic or ICD, coronary angiography and other tests are done to look for recurrent myocardial ischemia, which may require percutaneous coronary intervention or coronary artery bypass grafting. Ventricular tachycardia Nonsustained ventricular tachycardia (ie, < 30 seconds) and even sustained slow ventricular tachycardia (accelerated idioventricular rhythm) without hemodynamic instability do not usually require treatment in the first 24 to 48 hours (see figure Broad QRS Ventricular Tachycardia). Synchronized cardioversion is done for Polymorphic ventricular tachycardia Sustained (â‰¥ 30 seconds) monomorphic ventricular tachycardia Any ventricular tachycardia with symptoms of instability (eg, heart failure, hypotension, chest pain) Ventricular tachycardia without hemodynamic instability may be treated with IV lidocaine, procainamide, or amiodarone. Some clinicians also treat complex ventricular arrhythmias with magnesium sulfate 2 g IV over 5 minutes whether or
